- Home
- BANF vs LNTH Comparison
BANF vs LNTH Comparison
Compare BANF & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BANF | LNTH |
|---|---|---|
| Founded | 1984 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.8B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | BANF | LNTH |
|---|---|---|
| Price | $111.03 | $58.56 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $128.00 | $74.17 |
| AVG Volume (30 Days) | 115.0K | ★ 1.2M |
| Earning Date | 01-22-2026 | 11-06-2025 |
| Dividend Yield | ★ 1.75% | N/A |
| EPS Growth | ★ 13.17 | N/A |
| EPS | ★ 7.04 | 2.39 |
| Revenue | $666,553,000.00 | ★ $1,525,933,000.00 |
| Revenue This Year | $11.96 | $0.01 |
| Revenue Next Year | $3.80 | $1.24 |
| P/E Ratio | ★ $15.86 | $24.46 |
| Revenue Growth | ★ 9.57 | 1.95 |
| 52 Week Low | $97.02 | $47.25 |
| 52 Week High | $138.77 | $111.29 |
Technical Indicators
Market Signals| Indicator | BANF | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 49.23 | 60.04 |
| Support Level | $107.44 | $57.44 |
| Resistance Level | $112.53 | $59.30 |
| Average True Range (ATR) | 3.73 | 2.05 |
| MACD | 0.76 | 0.60 |
| Stochastic Oscillator | 66.10 | 81.83 |
Price Performance
Historical ComparisonAbout BANF BancFirst Corporation
BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.